Health Officials Consider Delaying Second Dose of Coronavirus Vaccine

Health Officials Consider Delaying Second Dose of Coronavirus Vaccine

Only 4.2 million Americans have received a first COVID-19 dose as of January 2.

Amid the COVID-19 vaccination rollout, there is debate over whether the second dose in the two-dose vaccination process should be delayed, according to the New York Times.

Although a combined 14 million doses of both the Pfizer and Moderna vaccines were shipped to the United States, only 4.2 million people have received their first dose. The delay in Americans receiving a first dose has led experts to believe that vaccinating a large number of people with the first round would be more beneficial than delivering second doses to those who have already been vaccinated.

There is evidence that the first dose offers protection from coronavirus—Britain will adopt the practice of one dose vaccinations.

“I would not be in favor of that,” said Dr. Anthony Fauci. “We’re going to keep doing what we’re doing.”

Opposition to the altered process of vaccination could be attributed to the fact that the vaccine trials were completed using the two-dose process.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Download Center

HTML - No Current Item Deck

OH&S Digital Edition

  • OHS Magazine Digital Edition - April 2021

    April 2021


      Tips on Creating an Effective Electrical PPE Programs
      Considerations for Choosing Eye Protection
      A New Paradigm for Reducing Contaminated Welds
      Limiting the Risk of Exposure with the Correct PPE
    View This Issue